Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: A cross-sectional analysis of data from an Australian cohort

Arthritis Research and Therapy

Volumn 13, Issue 6, 2011, Pages

  Nikpour, Mandana ^a,b   Hissaria, Pravin ^c,d   Byron, Jillian ^b   Sahhar, Joanne ^e   Micallef, Maree ^b   Paspaliaris, William ^b   Roddy, Janet ^f   Nash, Peter ^g   Sturgess, Alan ^h   Proudman, Susanna ^c   Stevens, Wendy ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

^d INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^e MONASH MEDICAL CENTRE   (Australia)

^f ROYAL PERTH HOSPITAL   (Australia)

^g Sunshine Coast Rheumatology   (Australia)

^h ST GEORGE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CARDIOLIPIN ANTIBODY; CENTROMERE ANTIBODY; CREATINE KINASE; CREATININE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DNA DIRECTED RNA POLYMERASE III; DNA DIRECTED RNA POLYMERASE III ANTIBODY; ENZYME ANTIBODY; HYDROXYCHLOROQUINE; LUPUS ANTICOAGULANT; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHOLIPID ANTIBODY; PREDNISOLONE; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN ANTIBODY; RITUXIMAB; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG; AUTOANTIBODY;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTEROID THERAPY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; JOINT CONTRACTURE; KIDNEY DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MELANOMA; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOSITIS; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDY; RAYNAUD PHENOMENON; SCORING SYSTEM; SKIN CANCER; SKIN DISEASE; SMOKING; SYNOVITIS; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE; AUSTRALIA; BLOOD; IMMUNOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; RISK ASSESSMENT; RISK FACTOR; SKIN; STATISTICAL MODEL;

AGED; AUSTRALIA; AUTOANTIBODIES; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; RNA POLYMERASE III; SCLERODERMA, SYSTEMIC; SKIN;

EID: 84055178102     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3544     Document Type: Article

References (22)

1. Nikpour M, Stevens WM, Herrick AL, Proudman SM. Epidemiology of systemic sclerosis. Best Pract Res Clin Rheumatol 2010, 24:857-869. 10.1016/j.berh.2010.10.007, 21665131.
2. Okano Y, Steen VD, Medsger TA. TextAutoantibody reactive with RNA polymerase III in systemic sclerosis. Annals Internal Med 1993, 119:1005-1013.
3. Kuwana M, Kimura K, Kawakami Y. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay. Arthritis Rheum 2002, 46:2742-2747. 10.1002/art.10521, 12384934.
4. Nihtyanova SI, Parker JC, Black CM, Bunn CC, Denton CP. A longitudinal study of anti-RNA polymerase III antibody levels in systemic sclerosis. Rheumatology 2009, 48:1218-1221. 10.1093/rheumatology/kep215, 19696067.
5. Faucher B, Stein P, Granel B, Weiller PJ, Disdier P, Serratrice J, Harle JR, Durand JM, Frances Y, Guis S, Pham T, Bardin N, Sanmarco M. Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma. Eur J Internal Med 2010, 21:114-117.
6. Meyer O, De Chaisemartin L, Nicaise-Roland P, Cabane J, Tubach F, Dieude P, Hayem G, Palazzo E, Chollet-Martin S, Kahan A, Allanore Y. Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study. J Rheumatol 2010, 37:125-130. 10.3899/jrheum.090677, 19918031.
7. Meyer OC, Fertig N, Lucas M, Somogyi N, Medsger TA. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J Rheumatol 2007, 34:104-109.
8. Bunn CC, Denton CP, Shi-Wen X, Knight C, Black CM. Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Br J Rheumatol 1998, 37:15-20. 10.1093/rheumatology/37.1.15, 9487245.
9. Hamaguchi Y, Hasegawa M, Fujimoto M, Matsushita T, Komura K, Kaji K, Kondo M, Nishijima C, Hayakawa I, Ogawa F, Kuwana M, Takehara K, Sato S. The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis. Br J Dermatol 2008, 158:487-495. 10.1111/j.1365-2133.2007.08392.x, 2344460, 18205876.
10. Santiago M, Baron M, Hudson M, Burlingame RW, Fritzler MJ. Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA. J Rheumatol 2007, 34:1528-1534.
11. Kuwana M, Okano Y, Pandey JP, Silver RM, Fertig N, Medsger TA. Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis. Arthritis Rheum 2005, 52:2425-2432. 10.1002/art.21232, 16052583.
12. Penn H, Howie AJ, Kingdon EJ, Bunn CC, Stratton RJ, Black CM, Burns A, Denton CP. Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM 2007, 100:485-494. 10.1093/qjmed/hcm052, 17601770.
13. Satoh T, Ishikawa O, Ihn H, Endo H, Kawaguchi Y, Sasaki T, Goto D, Takahashi K, Takahashi H, Misaki Y, Mimori T, Muro Y, Yazawa N, Sato S, Takehara K, Kuwana M. Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay. Rheumatology 2009, 48:1570-1574. 10.1093/rheumatology/kep290, 19808694.
14. Airo P, Ceribelli A, Cavazzana I, Taraborelli M, Zingarelli S, Franceschini F. Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies. J Rheumatol 2011, 38:1329-1334. 10.3899/jrheum.101144, 21459934.
15. Shah AA, Rosen A, Hummers L, Wigley F, Casciola-Rosen L. Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies. Arthritis Rheum 2010, 62:2787-2795. 10.1002/art.27549, 2946521, 20506513.
16. Masi AT, Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheumatism 1980, 23:581-590. 10.1002/art.1780230510, 7378088, Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980).
17. LeRoy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001, 28:1573-1576.
18. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, Mayes M, Collier D. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995, 22:1281-1285.
19. Hamaguchi Y, Fujimoto M, Matsushita T, Hasegawa M, Takehara K, Sato S. Elevated serum insulin-like growth factor (IGF-1) and IGF binding protein-3 levels in patients with systemic sclerosis: possible role in development of fibrosis. J Rheumatol 2008, 35:2363-2371. 10.3899/jrheum.080340, 19004037.
20. Bussone G, Berezne A, Pestre V, Guillevin L, Mouthon L. The scleroderma kidney: progress in risk factors, therapy, and prevention. Curr Rheumatol Rep 2011, 13:37-43. 10.1007/s11926-010-0145-7, 21061100.
21. Steen VD, Medsger TA. Improvement in skin thickening in systemic sclerosis associated with improved survival. Arthritis Rheum 2001, 44:2828-2835. 10.1002/1529-0131(200112)44:12<2828::AID-ART470>3.0.CO;2-U, 11762943.
22. Leiter U, Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer - the role of sunlight. Adv Exp Med Biol 2008, 624:89-103. 10.1007/978-0-387-77574-6_8, 18348450.